Page 75 - GALENIKA MEDICAL JOURNAL

32. Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. 39. Elobeid A, Libard S, Leino M, Popova SN, Alafuzoff I. Altered Proteins in
Association Between Longitudinal Plasma Neurofilament Light and the Aging Brain. J Neuropathol Exp Neurol. 2016 Apr;75(4):316-25.
Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol.
2019 Jul 1;76(7):791-9. 40. Mattsson N, Rosén E, Hansson O, Andreasen N, Parnetti L, Jonsson
M, et al. Age and diagnostic performance of Alzheimer disease CSF
33. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal biomarkers. Neurology. 2012 Feb 14;78(7):468-76.
PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential
Outcome Measure in Alzheimer's Disease Treatment Studies. Am J 41. Tang Y, Whitman GT, Lopez I, Baloh RW. Brain volume changes on
Psychiatry. 2002 May;159(5):738-45. longitudinal magnetic resonance imaging in normal older people. J
Neuroimaging. 2001 Oct;11(4):393-400
34. Portelius E, Olsson B, Höglund K, Cullen NC, Kvartsberg H,
Andreasson U, et al. Cerebrospinal fluid neurogranin concentration 42. Haeberlein SB, von Hehn C, Tian Y, Chalkias S, Muralidharan KK, Chen
in neurodegeneration: relation to clinical phenotypes and T, et al. Topline results from phase 3 aducanumab studies Clinical Trials
neuropathology. Acta Neuropathol. 2018 Sep;136(3):363-76. on Alzheimer’s Disease. 2019.
35. Casaletto KB, Elahi FM, Bettcher BM, Neuhaus J, Bendlin BB, Asthana
S, et al. Neurogranin, a synaptic protein, is associated with memory
independent of Alzheimer biomarkers. Neurology. 2017 Oct Konflikt interesa: Nema
24;89(17):1782-8.
36. Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of Primljeno: 24. 01. 2023.
TREM2 in Alzheimer's disease. Mol Neurodegener. 2018 Dec 20;13(1):66. Prihvaćeno: 17. 02. 2023.
37. Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, et Onlajn: 01. 03. 2023.
al. Current state of Alzheimer's fluid biomarkers. Acta Neuropathol.
2018 Dec;136(6):821-53.
38. Brookmeyer R, Abdalla N. Estimation of lifetime risks of Alzheimer's
disease dementia using biomarkers for preclinical disease. Alzheimers
Dement. 2018 Aug;14(8):981-8.

REVIJALNI RADOVI Galenika Medical Journal, 2023; 2(5):67-73. 73